Medication info

Conex Tablets 10/160 mg

Prescription medicationExpired
Ingredient · strength
Valsartan›Strength being verifiedAmlodipine Besylate›Strength being verified
Manufacturer / importer
Bionex Co., Ltd.
Appearance
Bright yellow, egg-shaped film-coated tablets
Packaging
28 tablets/box [14 tablets/PTP×2], 30 tablets/bottle
Approval status
Expired

MFDS item code 201309122 · Approved 2013.08.30

This product's status changed to Expired on 2023.08.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with amlodipine·valsartan monotherapy
Who uses it
Adults · Children
Adult dosage
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. * Valsartan/amlodipine besylate combination 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
Children's dosage
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with amlodipine·valsartan monotherapy

  • Essential hypertension
View approved original text

For patients with essential hypertension, when blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan, this medication assists in lowering blood pressure more effectively. It combines the effects of both drugs to maintain stable blood pressure, thereby reducing the risk of cardiovascular complications. Thus, it is used in the treatment of essential hypertension.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. * Valsartan/amlodipine besylate combination 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.

Children's dosage

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication may cause serious harm to the fetus and newborn if taken during the second or third trimester of pregnancy, so it should be stopped immediately upon confirmation of pregnancy. This medication should not be used by individuals with allergies to its active ingredients or similar class of drugs, pregnant women or women who may become pregnant, breastfeeding women, patients with severe kidney or liver disease, or certain heart condition patients. Particular caution is needed when using this medication in cases of dehydration or hyponatremia, hyperkalemia, issues with renal blood vessels, recent kidney transplant patients, patients with a history of vascular swelling, or patients after heart failure or myocardial infarction. Various side effects may appear during treatment, such as headache, dizziness, edema, blood pressure drop, gastrointestinal symptoms, skin rash; consult a healthcare professional if any unusual symptoms occur. Caution is advised when driving or operating machinery due to possible dizziness or fatigue. This medication may interact with other antihypertensive drugs, potassium supplements, certain anti-inflammatory agents, and drugs affecting liver function; if taking any other medications, be sure to inform your healthcare provider. It is recommended that pregnant or breastfeeding women do not use this medication, particularly after the second trimester, due to potential risks to the fetus. Safety and efficacy have not been sufficiently established for children, so use is not recommended. In case of overdose, severe hypotension or heart problems may occur, so it is necessary to be careful not to exceed the prescribed dose. Regular monitoring of blood pressure and blood tests to check kidney function and electrolyte status while on this medication is important.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, urinary frequency disorder, erectile dysfunction, edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, muscle pain, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, emotional changes, tremors, sensory loss, dysgeusia, peripheral neuropathy, excessive muscle tension, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, respiratory distress, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, muscle pain, urinary dysfunction, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitation, sensory loss, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent exposure to air or moisture. It is recommended that the storage temperature be maintained at room temperature between 1°C and 30°C. This will help maintain the effectiveness of the medication for a longer time.

Appearance and packaging

Appearance

Bright yellow, egg-shaped film-coated tablets

Package unit

28 tablets/box [14 tablets/PTP×2], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.